POLD1 and endometrial cancer: We also evaluated the effect of POLD1 mutation on patient survival and found that POLD1 mutation was positively correlated with Progression Free Survival (PFS), Disease Specific Survival (DSS) and OS in patients with endometrial cancer (Supplementary Fig. 3b–d).